US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 21, 2012 (14 years ago)

Insulin

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

What was recalled

INSULIN, LO-DOSE (FROM HUMALOG) 10 UNITS/ML INJECTABLE 10 ML (1 PRODUCT)

Recalling firm
Franck's Lab Inc., d.b.a. Franck's Compounding Lab
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1547-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Insulin recalls

See all
Class II · Moderate risk Completed

Sterile Diluent

Reason CGMP Deviations

Eli Lilly & Company D-0445-2024
Class II · Moderate risk Ongoing

Admelog

Reason Lack of Assurance of Sterility: Malformed crimped collar seal

Sanofi-Aventis U.S. LLC NDC 0024-5926-05 D-0575-2023
Class I · High risk Terminated

Insulin Glargine

Reason Labeling: Missing label: Label missing from some prefilled pens.

Mylan Pharmaceuticals Inc NDC 49502-394-71 D-1292-2022
Class I · High risk Terminated

Insulin Glargine

Reason Labeling: Missing label on the vial

Mylan Pharmaceuticals Inc NDC 49502-393-80 D-0845-2022
Class I · High risk Completed

Humalog KwikPen

Reason TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Cardinal Health Inc. NDC 0002-8799-59 D-0882-2022